Drug Shortage Report for TARO-DASATINIB
| Report ID | 173713 |
| Drug Identification Number | 02499304 |
| Brand name | TARO-DASATINIB |
| Common or Proper name | DASATINIB |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DASATINIB |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | L01EA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-01 |
| Estimated end date | 2023-10-06 |
| Actual end date | 2023-09-26 |
| Shortage status | Resolved |
| Updated date | 2023-10-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.